This compound is a derivative of abiraterone acetate, specifically recognized as an impurity associated with the manufacture of the pharmaceutical active ingredient. It features a steroidal backbone with a pyridine ring and an ester functional group, and its stereochemistry is well-defined.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2484719-10-8
(3beta)-16-[(3beta)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
Abiraterone related compound
17-(3-Pyridinyl)-3-propanoate-androsta-5,16-dien-3-ol
active pharmaceutical ingredient
Abiraterone Impurity 54
Reference standard for impurity testing
3-Deoxy-3-chloroabiraterone (Mixture of Diastereomers)
Abiraterone acetate impurity
Beta-Epoxyabiraterone acetate
Active pharmaceutical ingredient for cancer
Alpha-Epoxyabiraterone acetate
pharmaceutical raw material
Dantrolene sodium hemiheptahydrate
muscle relaxant active pharmaceutical ingredient
Aceglutamide
nootropic and antiulcer agent
[(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
UVIQSJCZCSLXRZ-BRSOJCHPSA-N
CC(=O)O[C@@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
—